Related Experiment Videos
High-throughput cell analysis using multiplexed array technologies
1Virtual Arrays, 1190 Bordeaux Drive, Sunnyvale, CA 94089, USA.
Drug Discovery Today
|January 28, 2003
Summary
New cell-array technologies enhance primary screening by providing more biologically relevant data. This accelerates drug discovery, reducing the time and cost of developing new medicines.
Area of Science:
- Biotechnology
- Drug Discovery
- Cell Biology
Background:
- Increasing demand for biologically relevant data in high-throughput screening (HTS).
- Growing use of cell-based assays in HTS laboratories.
- Need for advanced technologies to improve data quality and quantity.
Purpose of the Study:
- To compare array strategies for integrating multiplexed cell-based assays into HTS.
- To highlight the advantages of new cell-array technologies.
- To demonstrate the potential of these technologies in accelerating drug discovery.
Main Methods:
- Review and comparison of existing and emerging cell-array technologies (positional and non-positional formats).
- Analysis of data quality and quantity generated by these technologies.
- Evaluation of analytical approaches for large datasets from cell-based screens.
Main Results:
- Cell-array technologies offer improved data quality and quantity from cell-based assays.
- Both positional and non-positional array formats present unique advantages.
- New analytical methods enable deeper insights from screening data.
Conclusions:
- Integration of multiplexed cell-based assays with HTS via array technologies is feasible.
- These advancements can significantly condense drug discovery timelines and reduce costs.
- The synergy of cell-based assays, array tech, and analytics promises faster clinical translation.